Modulation of endogenous glutathione availability

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 2, Issue 6, 1999, Pages 487-492

  Wernerman, Jan ^a   Hammarqvist, Folke ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXO 4 THIAZOLIDINECARBOXYLIC ACID; 2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID; ACETYLCYSTEINE; CYSTEINE; GLUTAMINE; GLUTATHIONE; PROTEIN PRECURSOR; PYROGLUTAMIC ACID; THIAZOLE DERIVATIVE; THIAZOLIDINE DERIVATIVE;

ANIMAL; BIOSYNTHESIS; HUMAN; METABOLISM; REVIEW;

ACETYLCYSTEINE; ANIMALS; CYSTEINE; GLUTAMINE; GLUTATHIONE; HUMANS; PROTEIN PRECURSORS; PYRROLIDONECARBOXYLIC ACID; THIAZOLES; THIAZOLIDINES;

EID: 0033219081     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-199911000-00010     Document Type: Article

References (64)

1. Andersen ME. Glutathione: an overview of biosynthesis and modulation. Chemico-Biol Interact 1998; 111:1-14.
2. Andersson ME, Luo J-L. Glutathione therapy: from prodrugs to genes. Semin Liver Dis 1998; 18:415-424. This is a comprehensive up-to-date review.
3. Duarte JA, Gloser S, Remiao F, Carvalho F, Bastos ML, Scares JM, Appell HJ. Administration of tourniquet. I. Are oedema and oxidative stress related to each other and to the duration of ischemia in reperfused skeletal muscle? Arch Orthopaed Trauma Surg 1997; 116:97-100.
4. Sirsjö A, Arstrand K, Kagedal B, Nylander G, Gidlof A. In situ microdialysis for monitoring of extracellular glutathione levels in normal, ischemic and post-ischemic skeletal muscle. Free Rad Res 1996; 25:385-391.
5. Westman B, Johansson G, Luo J-L, Sōderlund K, Wernerman J, Hammarqvist F. Effects of ischemia and reperfusion on glutathione and energy content in skeletal muscle during elective surgery of abdominal aortic surgery. Clin Nutr 1999; 18 (suppl 1):2.
6. Luo J-L, Hammarqvist F, Andersson K, Wernerman J. Skeletal muscle glutathione following surgical trauma. Ann Surg 1996; 223:420-427.
7. Hammarqvist F, Luo J-L, Andersson K, Cotgreave IA, Wernerman J. Skeletal muscle glutathione is depleted in critically ill patients. Crit Care Med 1997; 25:78-84.
8. Luo J-L, Hammarqvist F, Andersson K, Wernerman J. Surgical trauma decreases the synthesis of glutathione in skeletal muscle. Am J Physiol 1998; 275:E359-E365. This paper presents findings on enzyme activities of the glutathione cycle after elective surgery.
9. Mathru M, Dries DJ, Barnes L, Tonino P, Sukhani R, Rooney MW. Tourniquet-induced exsanguination in patients requiring lower limb surgery. An ischemia-reperfusion model of oxidant and antioxidant metabolism. Anesthesiology 1996; 84:14-22.
10. Kurokawa T, Kobayashi H, Nonami T, Harada A, Nakao A, Takagi H. Mitochondrial glutathione redox and energy producing function during liver ischemia and reperfusion. J Surg Res 1996; 66:1-5.
11. Luthen R, Grendell JH, Niederau C, Haussinger D. Trypsinogen activation and glutathione content are liked to pancreatic injury in models of biliary acute pancreatitis. Int J Pancreatol 1998; 2483:193-202. The suggestion is made that glutathione depletion is a mechanism for development for pancreatitis.
12. Rabinovic AD, Hastings TG. Role of endogenous glutathione in the oxidation of dopamine. J Neurochem 1993; 71:2071-2078.
13. Mehta A, Singh S, Ganguly NK. Impairment of intestinal mucosal antioxidant defense system during Salmonella typhimurium infection. Dig Dis Sci 1998; 43:646-651.
14. Celli A, Que FG, Gores GJ, LaRusso NF. Glutathione depletion is associated with decreased Bcl-2 expression and increased apoptosis in cholangiocytes. Am J Physiol 1998; 275(4 Pt 1):G749-G757.
15. Froissard P, Monrocq H, Duval D. Role of glutathione metabolism in the glutamate-induced programmed cell death of neuronal-like PC12 cells. Eur J Pharmacol 1997; 326:93-99.
16. Lucas JH, Wheeler DG, Emery DG, Mallery SR. The endogenous antioxidant glutathione as a factor in the survival of physically injured mammalian spinal cord neurons. J Neuropathol Exp Neurol 1998; 57:937-954.
17. Shibata S, Tominaga K, Watanabe S. Glutathione protects against hypoxic/ hypoglycemic decreases in 2-deoxyglucose uptake and presynaptic spikes in hippocampal slices. Eur J Pharmacol 1995; 273:191-195.
18. Martinez G, Carnazza ML, Campisi A, Sorrenti V, Di Giacomo C, Perez-Polo JR, Vanella A. Effects of glutathione depletors on post-ischemic reperfusion in rat brain. Neurochem Res 1998; 23:961-968.
19. Sierra-Rivera E, Summar ML, Dasouki M, Krishnamani MR, Phillips JA, Freeman ML. Assignment of the gene (GLCLC) that encodes the heavy subunit of gamma-glutamylcysteine synthetase to human chromosome 6. Cytogenet Cell Genet 1995; 70:278-279.
20. Shi ZZ, Carter BZ, Habib GM, He X, Sazer S, Lebovitz RM, Lieberman MW. A single mouse glutathione synthetase gene encodes six mRNAs with different 5′ ends. Arch Biochem Biophys 1996; 331:215-224.
21. Cai J, Huang ZZ, Lu SC. Differential regulation of gamma-glutamylcysteine synthetase heavy and light subunit gene expression. Biochem J 1997; 326 (Pt 1):167-172.
22. Sierra-Rivera E, Dasouki M, Summar ML, Krishnamani MR, Meredith M, Rao PN, et al. Assignment of the human gene (GLCLR) that encodes the regulatory subunit of gamma-glutamylcysteine synthetase to chromosome 1p21. Cytogenet Cell Genet 1996; 72:252-254.
23. Mulcahy RT, Gipp JJ. Indentification of a putative antioxidant response element in the 5′-flanking region of the human gamma-glutamylcysteine synthetase heavy subunit gene. Biochem Biophys Res Commun 1995; 209:227-233.
24. Sen CK. Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem Pharmacol 1998; 55:1747-1758.
25. Morales A, Garcia-Ruiz C, Miranda M, Mari M, Colell A, Ardite E, Fernandez-Checa JC. Tumor necrosis factor increases hepatocellular glutathione by transcriptional regulation of the heavy subunit chain of gamma-glutamylcysteine synthetase. J Biol Chem 1997; 272:30371-30379.
26. Arsalane K, Dubois CM, Muanza T, Begin R, Boudreau F, Asselin C, Cantin AM. Transforming growth factor-beta 1 is a potent inhibitor of glutathione synthesis in the lung epithelial cell line A549: transcriptional effect on the GSH rate-limiting enzyme gamma-glutamylcysteine synthetase. Am J Respir Cell Mol Biol 1997; 17:599-607.
27. Dahl N, Pigg M, Ristoff E, Gali R, Carlsson B, Mannervik B, et al. Missense mutations in the human glutathione synthetase gene result in severe metabolic acidosis, 5-oxoprolinuria, hemolytic anemia and neurological dysfunction. Hum Mol Genet 1997; 6:1147-1152.
28. Herzenberg LA, De Rosa SC, Dubs JG, Roederer M, Anderson MT, Ela SW, Deresinski SC. Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci USA 1997; 94:1967-1972.
29. Hack V, Breitkreutz R, Kinscherf R, Rohrer H, Bartsch P, Taut F, et al. The redox state as a correlate of senescence and wasting and as a target for therapeutic intervention. Blood 1998; 92:59-67.
30. Roberts RL, Aroda VR, Ank BJ. N-acetylcysteine enhances antibody-dependent cellular cytotoxity in neutrophils and mononuclear cells from healthy adults and human immunodeficiency virus-infected patients. J Infect Dis 1995; 172:1492-1502.
31. Bernard GR, Wheeler AP, Arons MM, Morris PE, Paz HL, Russel JA, Wright PE, The Antioxidant in ARDS Study Group. A trial of antioxidants N-acetylcysteine and procysteine in ARDS. Chest 1997; 112:164-172.
32. Ho WZ, Starr SE, Sison A, Douglas SD. L-2-oxothiazolidine-4-carboxylic acid inhibits human immunodeficiency virus type 1 replication in mononuclear phagocytes and lymphocytes. Clin Diag Lab lmmunol 1997; 4:352-357.
33. Emonet N, Leccia MT, Favier A, Beani JC, Richard MJ. Thiols and selenium: protective effect on human skin fibroblasts exposed to UVA radiation. J Photochem Photobiol Biol 1997; 40:84-90.
34. Gross CL, Giles KC, Smith WJ. L-oxothiazolidine 4-carboxylate pretreatment of isolated human peripheral blood lymphocytes reduces sulfur mustard cytotoxity. Cell Biol Toxicol 1997; 13:167-173.
35. Lederman MM, Georges D, Dando S, Schmelzer R, Averill L, Goldberg D. L-2-oxothiazolidine-4-carboxylic acid (procysteine) inhibits expression of the human immunodeficiency virus and expression of the interleukin-2 receptor alpha chain. J Acquir Immun Defic Syndr 1995; 8:107-115.
36. Chen P, Bauer G, Mitchell J, Factor R, Markham R, Schwartz DH. N-acetylcysteine and L-2-oxothiazolidine-4-carboxylic acid enhance contact-dependent growth of HIV in resting peripheral blood mononuclear cells (PBMC) in vitro and increase recovery of HIV from human-PBMC SCID mice. AIDS 1997; 11:33-41.
37. Simon G, Moog C, Obert G. Effects of glutathione precursors on human immunodeficiency virus replication. Chemico-Biol Interact 1994; 91:217-224.
38. Luthen R, Grendell JH, Haussinger D, Niederau C. Beneficial effects of L-2-oxothiazolidine-4-carboxylate on cerulein pancreatitis in mice. Gastroenterology 1997; 112:1681-1691.
39. Levy MA, Sikorski B, Bray TM. Selective elevation of glutathione levels in target tissues with L-2-oxothiazolidine-4-carboxylate (OTC) protects against hyperoxia-induced lung damage in protein-energy malnourished rats: implications for a new treatment strategy. J Nutr 1998; 128:671-676.
40. Korybalska K, Breborowicz A, Wieczorowska-Tobis K, Polubinska A, Moberly J, Martis L, Oreopoulos DG. Alterations of intraperitoneal inflammation by the addition of L-2-oxothiazolidine-carboxylate. Adv Periton Dial 1997; 13:197-200.
41. Jain A, Madsen DC, Auld PA, Frayer WW, Schwartz MK, Meister A, Martensson J. L-2-oxothiazolidine-4-carboxylate, a cysteine precursor, stimulates growth and normalises tissue glutathione concentrations in rats fed a sulfur amino acid-deficient diet. J Nutr 1995; 125:851-856.
42. Barditch-Crovo P, Noe D, Skowron G, Lederman M, Kalayjian RC, Borum P, et al. A phase I/II evaluation of oral L-2-oxothiazolidine-4-carboxylic acid in asymptomatic patients infected with human immunodeficiency virus. J Clin Pharmacol 1998; 38:357-363.
43. Holmes RP, Assimos DG, Leaf CD, Whalen JJ. The effects of (L)-2-oxothiazolidine-carboxylate on urinary oxalate excretion. J Ural 1997; 158:34-37.
44. Moberly JB, Logan J, Borum PR, Story KO, Webb LE, Jassal SV, et al. Elevation of whole-blood glutathione in peritoneal dialysis patients by L-2-oxothiazolidine-4-carboxylate, a cysteine prodrug (Procysteine). J Am Soc Nephrol 1998; 9:1093-1099. This study demonstrates an effect of OTC on whole-blood glutathione concentration in peritoneal dialysis patients.
45. Vita JA, Frei B, Holbrook M, Gokce N, Leaf C, Keaney JF Jr. L-2-oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease. J Clin Invest 1998; 101:1408-1414. An effect of OTC on vasodilatation of the brachial artery in patients with coronary artery disease is demonstrated.
46. Goto H, Tachi K, Arisawa T, Niwa Y, Hayakawa T, Sugiyama S. Effects of gamma-glutamylcysteine ethyl ester in cisplatin-induced changes in prostanoid concentrations in rat gastric and colonic mucosa. Cancer Detect Prevent 1998; 22:153-160.
47. Nishida K, Ohta Y, Ishiguro I. Gamma-glutamylcysteinylethyl ester attenuates progression of carbon tetrachloride-induced acute liver injury in mice. Toxicology 1998; 126:55-63.
48. Minhas HS, Thornalley PJ. Comparison of the delivery of reduced glutathione into P388D1 cells by reduced glutathione and its mono- and diethyl ester derivatives. Biochem Pharmacol 1995; 49:1475-1482.
49. Kobayashi S, Takehana M, Tohyama C. Glutathione isopropyl ester reduces UVB-induced skin damage in hairless mice. Photochem Photobiol 1996; 6381:106-110.
50. Cao Y, Feng Z, Hoos A, Klimberg VS. Glutamine enhances gut glutathione production. J Parent Enter Nutr 1998; 22:224-227. This study shows that glutamine influences glutathione concentration in the gut.
51. Collins CL, Wasa M, Souba WW, Abcouwer SF. Determinants of glutamine dependence and utilization by normal and tumor-derived breast cell lines. J Cell Physiol 1998; 176:166-178.
52. O'Riordain MG, De Beaux A, Fearon KC. Effect of glutamine on immune function in the surgical patient. Nutrition 1996; 12 (suppl):S82-S84.
53. Denno R, Rounds JD, Faris R, Holejko LB, Wilmore DW. Glutamine-enriched total parenteral nutrition enhances plasma glutathione in the resting state. J Surg Res 1996; 61:35-38.
54. Basoglu M, Yildirgan I, Akcay F, Kiziltunc A, Kavak I, Oren D. Glutathione and nitric oxide concentrations in glutamine-infused rabbits with intestinal ischaemia/reperfusion. Eur J Clin Chem Clin Biochem 1997; 35:415-419.
55. Goringe AP, Brown S, O'Callaghan U, Rees J, Jebb S, Elia M, Poynton CH. Glutamine and vitamin E in the treatment of hepatic veno-occlusive disease following high-dose chemotherapy. Bone Marrow Transplant 1998; 21:829-832. This paper provides an interesting case report of an effect of glutamine on hepatic veno-occlusive disease.
56. Youn YK, Suh GJ, Jung SE, Oh SK, Demling R. Recombinant human growth hormone decreases lung and liver tissue lipid peroxidation and increases antioxidant activity after thermal injury in rats. J Burn Care Rehab 1998; 19:542-548. Growth hormone can influence glutathione metabolism.
57. Foster LH, Sumar S. Selenium in health and disease: a review. Crit Rev Food Sci Nutr 1997;37:211-228.
58. Tanguy S, Boucher F, Besse S, Ducros V, Favier A, de Leiris J. Trace elements and cardioprotection: increasing endogenous glutathione peroxidase activity by oral selenium supplementation in rats limits reperfusion-induced arrhythmias. J Trace Elements Med Biol 1998; 12:28-38.
59. Grimble RF, Grimble GK. Immunonutrition: role of sulfur amino acids, related amino acids, and polyamines. Nutrition 1998; 14:605-610. This is an outstanding review, with a focus on the sulphur-containing amino acids.
60. Hunter EA, Grimble RF. Dietary sulphur amino acid adequacy influences glutathione synthesis and glutathione-dependent enzymes during the inflammatory response to endotoxin and tumour necrosis factor-alpha in rats. Clin Sci 1997;92:297-305.
61. Ookhtens M, Kaplowitz N. Role of the liver in interorgan homeostatis of glutathione and cyst(e)ine. Semin Liver Dis 1998; 18:313-329.
62. Hack V, Gross A, Kinscherf R, Bockstette M, Fiers W, Berke G, Droge W. Abnormal glutathione and sulfate levels after interleukin 6 treatment and in tumor-induced cachexia. FASEB J 1996; 10:1219-1226.
63. Droge W, Holm E. Role of cysteine and glutathione in HIV infection and other diseases associated with muscle wasting and immunological dysfunction. FASEB J 1997; 11:1077-1089.
64. Kranich O, Hamprecht B, Dringen R. Different preferences in the utilization of amino acids for glutathione synthesis in cultured neurons and astroglial cells derived from rat brain. Neurosci Lett 1996; 219:211-214.